Advanced search
Publication Cover
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration Volume 20, 2019 - Issue 1-2
Submit an article Journal homepage
1,945
Views
50
CrossRef citations to date
0
Altmetric
Research Article

Efficacy and tolerability of EH301 for amyotrophic lateral sclerosis: a randomized, double-blind, placebo-controlled human pilot study

JosÉ E. de la RubiaDepartment of Nursing, Catholic University San Vicente Mártir, Valencia, Spain, View further author information
,
Eraci DrehmerDepartment of Health and Functional Valorization, Catholic University San Vicente Martir, Valencia, Spain, View further author information
,
JosÉ L. PlateroDepartment of Nursing, Catholic University San Vicente Mártir, Valencia, Spain, View further author information
,
MarÍa BenllochDepartment of Nursing, Catholic University San Vicente Mártir, Valencia, Spain, View further author information
,
Jordi Caplliure-LlopisPrimary Care Service, University Hospital La Ribera, Alcira, Spain, View further author information
,
Carlos Villaron-CasalesDepartment of Physiotherapy, European University of Valencia, Valencia, Spain, View further author information
,
Nieves de BernardoDepartment of Physiotherapy, European University of Valencia, Valencia, Spain, View further author information
,
Jorge AlarcÓnDepartment of Physiotherapy, European University of Valencia, Valencia, Spain, View further author information
,
Cristian FuenteDepartment of Nursing, Catholic University San Vicente Mártir, Valencia, Spain, View further author information
,
Sandra CarreraDepartment of Health Sciences, Catholic University San Vicente Martir, Valencia, Spain, View further author information
,
David SanchoDepartment of Nursing, Catholic University San Vicente Mártir, Valencia, Spain, View further author information
,
Pilar GarcÍa-PardoDepartment of Medicine, University Jaume I, Castellón, Spain, View further author information
,
Raquel PascualRehabilitation Service, General University Hospital, Valencia, Spain, View further author information
,
Marta JuÁrezClínica Artes & Timefit, Valencia, Spain, View further author information
,
María Cuerda-BallesterDepartment of Nursing, Catholic University San Vicente Mártir, Valencia, Spain, View further author information
,
Alfonso FornerDepartment of Nursing, Catholic University San Vicente Mártir, Valencia, Spain, View further author information
,
Sandra Sancho-CastilloDepartment of Nursing, Catholic University San Vicente Mártir, Valencia, Spain, View further author information
,
Carlos BarriosInstitute for Research on Musculoskeletal Disorders, Catholic University San Vicente Mártir, Valencia, Spain, View further author information
,
Elena ObradorDepartment of Physiology, University of Valencia, Valencia, Spain, View further author information
,
Patricia MarchioVirgen del Consuelo Hospital, Valencia, Spain, View further author information
,
Rosario SalvadorDepartment of Physiology, University of Valencia, Valencia, Spain, View further author information
,
Holly E. HolmesElysium Health, Inc., New York, NY, USA and View further author information
,
Ryan W. DellingerElysium Health, Inc., New York, NY, USA and View further author information
,
Leonard GuarenteElysium Health, Inc., New York, NY, USA and ;Department of Biology and Glenn Laboratories for the Science of Aging, MIT, Cambridge, MA, USAView further author information
&
José M. EstrelaDepartment of Physiology, University of Valencia, Valencia, Spain, Correspondence[email protected]
View further author information
 show all
Pages 115-122 | Received 02 Jul 2018, Accepted 04 Oct 2018, Published online: 22 Jan 2019

Citations (50)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Loreto Martinez-Gonzalez & Ana Martinez. (2023) Emerging clinical investigational drugs for the treatment of amyotrophic lateral sclerosis. Expert Opinion on Investigational Drugs 32:2, pages 141-160.
Read now
. (2019) ALSUntangled no. 49: resveratrol. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 20:7-8, pages 619-624.
Read now

Articles from other publishers (48)

Kaitlin A Freeberg, CeAnn C Udovich, Christopher R Martens, Douglas R Seals & Daniel H Craighead. (2023) Dietary Supplementation With NAD+-Boosting Compounds in Humans: Current Knowledge and Future Directions. The Journals of Gerontology: Series A 78:12, pages 2435-2448.
Crossref
Mariana BresqueDaniel EsteveMariana Pehar & Marcelo R. Vargas. (2023) Nicotinamide Adenine Dinucleotide (NAD + )-Dependent Signaling in Neurological Disorders . Antioxidants & Redox Signaling 39:16-18, pages 1150-1166.
Crossref
Shalender Bhasin, Douglas Seals, Marie Migaud, Nicolas Musi & Joseph A Baur. (2023) Nicotinamide Adenine Dinucleotide in Aging Biology: Potential Applications and Many Unknowns. Endocrine Reviews 44:6, pages 1047-1073.
Crossref
Edward Caddye, Julien Pineau, Joshua Reyniers, Itamar Ronen & Alessandro Colasanti. (2023) Lactate: A Theranostic Biomarker for Metabolic Psychiatry?. Antioxidants 12:9, pages 1656.
Crossref
Zeynep YILDIRIM, Dicle Naz TOKTAŞ, Öznur DEMİR, Zülfiye GÜL & Burcu ŞEN UTSUKARÇİ. (2023) Amyotrofik Lateral Skleroz Patofizyolojisi ve Tedavi YaklaşımlarıAn Evaluation of Amyotrophic Lateral Sclerosis and Current Situation in Its Treatment. Hacettepe University Journal of the Faculty of Pharmacy.
Crossref
Xiao Luo, Xiongbin Kang & Alexander Schönhuth. (2023) Predicting the prevalence of complex genetic diseases from individual genotype profiles using capsule networks. Nature Machine Intelligence 5:2, pages 114-125.
Crossref
Ao Li, Shuting Li, Jiashu Wang, Yunyun Chen & Ming Lu. (2022) Pterostilbene–Nicotinamide Cocrystal: A Case Report of Single Cocrystals Grown from Melt Microdroplets. Crystal Growth & Design 23:1, pages 6-10.
Crossref
A. Joseph Bloom, Xianrong Mao, Amy Strickland, Yo Sasaki, Jeffrey Milbrandt & Aaron DiAntonio. (2022) Constitutively active SARM1 variants that induce neuropathy are enriched in ALS patients. Molecular Neurodegeneration 17:1.
Crossref
Jonas Brorson Jensen, Ole L. Dollerup, Andreas B. Møller, Tine B. Billeskov, Emilie Dalbram, Sabina Chubanava, Mads V. Damgaard, Ryan W. Dellinger, Kajetan Trošt, Thomas Moritz, Steffen Ringgaard, Niels Møller, Jonas T. Treebak, Jean Farup & Niels Jessen. (2022) A randomized placebo-controlled trial of nicotinamide riboside and pterostilbene supplementation in experimental muscle injury in elderly individuals. JCI Insight 7:19.
Crossref
Jasmine A Fels, Gabriella Casalena, Csaba Konrad, Holly E Holmes, Ryan W Dellinger & Giovanni Manfredi. (2022) Gene expression profiles in sporadic ALS fibroblasts define disease subtypes and the metabolic effects of the investigational drug EH301. Human Molecular Genetics 31:20, pages 3458-3477.
Crossref
Débora Lanznaster, Giulia Dingeo, Rayhanatou Altine Samey, Patrick Emond & Hélène Blasco. (2022) Metabolomics as a Crucial Tool to Develop New Therapeutic Strategies for Neurodegenerative Diseases. Metabolites 12:9, pages 864.
Crossref
David G Le Couteur & Nir Barzilai. (2022) New horizons in life extension, healthspan extension and exceptional longevity. Age and Ageing 51:8.
Crossref
Xiaokai Zhang, Yang Zhang, Aijun Sun & Junbo Ge. (2022) The effects of nicotinamide adenine dinucleotide in cardiovascular diseases: Molecular mechanisms, roles and therapeutic potential. Genes & Diseases 9:4, pages 959-972.
Crossref
N. Ahmed, M.R. Baker & J. Bashford. (2022) The landscape of neurophysiological outcome measures in ALS interventional trials: A systematic review. Clinical Neurophysiology 137, pages 132-141.
Crossref
Gard Aasmund Skulstad Johanson, Ole-Bjørn Tysnes & Tale L. Bjerknes. (2022) Use of Off-Label Drugs and Nutrition Supplements among Patients with Amyotrophic Lateral Sclerosis in Norway. Neurology Research International 2022, pages 1-6.
Crossref
Laia Morató, Simone Astori, Ioannis Zalachoras, Joao Rodrigues, Sriparna Ghosal, Wei Huang, Isabelle Guillot de SuduirautJocelyn Grosse, Olivia ZanolettiLei Cao, Johan Auwerx & Carmen Sandi. (2022) eNAMPT actions through nucleus accumbens NAD + /SIRT1 link increased adiposity with sociability deficits programmed by peripuberty stress . Science Advances 8:9.
Crossref
Nancy Tarantino, Ileana Canfora, Giulia Maria Camerino & Sabata Pierno. (2022) Therapeutic Targets in Amyotrophic Lateral Sclerosis: Focus on Ion Channels and Skeletal Muscle. Cells 11:3, pages 415.
Crossref
Swati Dhasmana, Anupam Dhasmana, Acharan S. Narula, Meena Jaggi, Murali M. Yallapu & Subhash C. Chauhan. (2022) The panoramic view of amyotrophic lateral sclerosis: A fatal intricate neurological disorder. Life Sciences 288, pages 120156.
Crossref
Sílvia Cabré, Kenneth J. O’Riordan & John F. Cryan. 2022. Evolution, Biodiversity and a Reassessment of the Hygiene Hypothesis. Evolution, Biodiversity and a Reassessment of the Hygiene Hypothesis 339 392 .
Samuel Lundt & Shinghua Ding. (2021) NAD+ Metabolism and Diseases with Motor Dysfunction. Genes 12:11, pages 1776.
Crossref
Jiangwei Sun, Tingting Huang, Justine W. Debelius & Fang Fang. (2021) Gut microbiome and amyotrophic lateral sclerosis: A systematic review of current evidence. Journal of Internal Medicine 290:4, pages 758-788.
Crossref
Øyvind Strømland, Joseph Diab, Eugenio Ferrario, Lars J. Sverkeli & Mathias Ziegler. (2021) The balance between NAD+ biosynthesis and consumption in ageing. Mechanisms of Ageing and Development 199, pages 111569.
Crossref
Takashi Hosaka, Hiroshi Tsuji & Akira Tamaoka. (2021) Biomolecular Modifications Linked to Oxidative Stress in Amyotrophic Lateral Sclerosis: Determining Promising Biomarkers Related to Oxidative Stress. Processes 9:9, pages 1667.
Crossref
Elena Obrador, Rosario Salvador-Palmer, Rafael López-Blanch, Ryan W. Dellinger & José M. Estrela. (2021) NAD+ Precursors and Antioxidants for the Treatment of Amyotrophic Lateral Sclerosis. Biomedicines 9:8, pages 1000.
Crossref
Elena Obrador, Rosario Salvador-Palmer, Rafael López-Blanch, Ali Jihad-Jebbar, Soraya L. Vallés & José M. Estrela. (2021) The Link between Oxidative Stress, Redox Status, Bioenergetics and Mitochondria in the Pathophysiology of ALS. International Journal of Molecular Sciences 22:12, pages 6352.
Crossref
Jin-Hui Hor, Munirah Mohamad Santosa, Valerie Jing Wen Lim, Beatrice Xuan Ho, Amy Taylor, Zi Jian Khong, John Ravits, Yong Fan, Yih-Cherng Liou, Boon-Seng Soh & Shi-Yan Ng. (2020) ALS motor neurons exhibit hallmark metabolic defects that are rescued by SIRT3 activation. Cell Death & Differentiation 28:4, pages 1379-1397.
Crossref
Elena Obrador, Rosario Salvador, Patricia Marchio, Rafael López-Blanch, Ali Jihad-Jebbar, Pilar Rivera, Soraya L. Vallés, Salvador Banacloche, Javier Alcácer, Nuria Colomer, Javier A. Coronado, Sandra Alandes, Eraci Drehmer, María Benlloch & José M. Estrela. (2020) Nicotinamide Riboside and Pterostilbene Cooperatively Delay Motor Neuron Failure in ALS SOD1G93A Mice. Molecular Neurobiology 58:4, pages 1345-1371.
Crossref
Julia Casani-Cubel, María Benlloch, Claudia Emmanuela Sanchis-Sanchis, Raquel Marin, Jose María Lajara-Romance & Jose Enrique de la Rubia Orti. (2021) The Impact of Microbiota on the Pathogenesis of Amyotrophic Lateral Sclerosis and the Possible Benefits of Polyphenols. An Overview. Metabolites 11:2, pages 120.
Crossref
Cyril Jones Jagaraj, Sonam Parakh & Julie D. Atkin. (2021) Emerging Evidence Highlighting the Importance of Redox Dysregulation in the Pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Frontiers in Cellular Neuroscience 14.
Crossref
Cassandra Willyard. (2021) How gut microbes could drive brain disorders. Nature 590:7844, pages 22-25.
Crossref
Anthony J. Covarrubias, Rosalba Perrone, Alessia Grozio & Eric Verdin. (2020) NAD+ metabolism and its roles in cellular processes during ageing. Nature Reviews Molecular Cell Biology 22:2, pages 119-141.
Crossref
Daniele Orsucci, Elena Caldarazzo Ienco, Gabriele Siciliano & Michelangelo Mancuso. 2021. Clinical Bioenergetics. Clinical Bioenergetics 509 532 .
Jordi Caplliure-Llopis, Dolores Escrivá, María Benlloch, José Enrique de la Rubia Ortí, José María Estrela & Carlos Barrios. (2020) Poor Bone Quality in Patients With Amyotrophic Lateral Sclerosis. Frontiers in Neurology 11.
Crossref
Teresa Cunha-Oliveira, Liliana Montezinho, Catarina Mendes, Omidreza Firuzi, Luciano Saso, Paulo J. Oliveira & Filomena S. G. Silva. (2020) Oxidative Stress in Amyotrophic Lateral Sclerosis: Pathophysiology and Opportunities for Pharmacological Intervention. Oxidative Medicine and Cellular Longevity 2020, pages 1-29.
Crossref
Michael B. Zemel. (2020) Modulation of Energy Sensing by Leucine Synergy with Natural Sirtuin Activators: Effects on Health Span. Journal of Medicinal Food 23:11, pages 1129-1135.
Crossref
Na Xie, Lu Zhang, Wei Gao, Canhua Huang, Peter Ernst Huber, Xiaobo Zhou, Changlong Li, Guobo Shen & Bingwen Zou. (2020) NAD+ metabolism: pathophysiologic mechanisms and therapeutic potential. Signal Transduction and Targeted Therapy 5:1.
Crossref
Elena Obrador, Rosario Salvador, Rafael López-Blanch, Ali Jihad-Jebbar, Soraya L. Vallés & José M. Estrela. (2020) Oxidative Stress, Neuroinflammation and Mitochondria in the Pathophysiology of Amyotrophic Lateral Sclerosis. Antioxidants 9:9, pages 901.
Crossref
Dina Radenkovic, Reason & Eric Verdin. (2020) Clinical Evidence for Targeting NAD Therapeutically. Pharmaceuticals 13:9, pages 247.
Crossref
Zhi Dong Zhou & Eng King Tan. (2020) Oxidized nicotinamide adenine dinucleotide-dependent mitochondrial deacetylase sirtuin-3 as a potential therapeutic target of Parkinson’s disease. Ageing Research Reviews 62, pages 101107.
Crossref
Melanie R. McReynolds, Karthikeyani Chellappa & Joseph A. Baur. (2020) Age-related NAD+ decline. Experimental Gerontology 134, pages 110888.
Crossref
Lucia Sedlackova & Viktor I. Korolchuk. (2020) The crosstalk of NAD, ROS and autophagy in cellular health and ageing. Biogerontology 21:3, pages 381-397.
Crossref
Humberto Foyaca Sibat & Lourdes de Fátima Ibañez Valdés. 2020. Novel Aspects on Motor Neuron Disease. Novel Aspects on Motor Neuron Disease.
Benjamin A. Harlan, Kelby M. Killoy, Mariana Pehar, Liping Liu, Johan Auwerx & Marcelo R. Vargas. (2020) Evaluation of the NAD+ biosynthetic pathway in ALS patients and effect of modulating NAD+ levels in hSOD1-linked ALS mouse models. Experimental Neurology 327, pages 113219.
Crossref
Can Zhao, Wenjing Li, Haoyun Duan, Zongyi Li, Yanni Jia, Songmei Zhang, Xin Wang, Qingjun Zhou & Weiyun Shi. (2020) NAD + precursors protect corneal endothelial cells from UVB-induced apoptosis . American Journal of Physiology-Cell Physiology 318:4, pages C796-C805.
Crossref
Brian C. Gilmour, Ruben Gudmundsrud, Johannes Frank, Amund Hov, Sofie Lautrup, Yahyah Aman, Helge Røsjø, Charles Brenner, Mathias Ziegler, Ole-Bjørn Tysnes, Charalampos Tzoulis, Torbjørn Omland, Arne Søraas, Trygve Holmøy, Linda H. Bergersen, Jon Storm-Mathisen, Hilde Nilsen & Evandro F. Fang. (2020) Targeting NAD+ in translational research to relieve diseases and conditions of metabolic stress and ageing. Mechanisms of Ageing and Development 186, pages 111208.
Crossref
Elena Katsyuba, Mario Romani, Dina Hofer & Johan Auwerx. (2020) NAD+ homeostasis in health and disease. Nature Metabolism 2:1, pages 9-31.
Crossref
Chenglong Xie, Yahyah Aman, Bryan A. Adriaanse, M. Zameel Cader, Hélène Plun-Favreau, Jian Xiao & Evandro F. Fang. (2020) Culprit or Bystander: Defective Mitophagy in Alzheimer’s Disease. Frontiers in Cell and Developmental Biology 7.
Crossref
Sofie Lautrup, David A. Sinclair, Mark P. Mattson & Evandro F. Fang. (2019) NAD+ in Brain Aging and Neurodegenerative Disorders. Cell Metabolism 30:4, pages 630-655.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.